WinQure Medicine is a biotechnology company dedicated to developing antisense oligonucleotide (ASO) therapies for patients living with ultra-rare genetic diseases. Our mission is to create a scalable and sustainable framework that enables therapies to reach patients who are underserved by conventional drug development models.